Huber Capital Management LLC raised its position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 38.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,819 shares of the medical instruments supplier's stock after purchasing an additional 11,149 shares during the period. Huber Capital Management LLC owned 1.21% of Utah Medical Products worth $2,231,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also modified their holdings of the company. Tower Research Capital LLC TRC boosted its stake in Utah Medical Products by 172.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock worth $32,000 after purchasing an additional 328 shares during the period. Deutsche Bank AG purchased a new position in shares of Utah Medical Products in the 4th quarter valued at about $43,000. PNC Financial Services Group Inc. increased its holdings in shares of Utah Medical Products by 156.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier's stock valued at $50,000 after purchasing an additional 546 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in Utah Medical Products by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock valued at $56,000 after acquiring an additional 500 shares in the last quarter. Finally, Wells Fargo & Company MN increased its holdings in Utah Medical Products by 24.9% during the 4th quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock valued at $118,000 after acquiring an additional 384 shares in the last quarter. Institutional investors and hedge funds own 69.60% of the company's stock.
Utah Medical Products Stock Performance
NASDAQ:UTMD traded up $0.15 during mid-day trading on Monday, hitting $62.21. 12,162 shares of the company's stock traded hands, compared to its average volume of 14,120. Utah Medical Products, Inc. has a 1 year low of $51.26 and a 1 year high of $68.99. The company has a market cap of $199.45 million, a PE ratio of 16.63 and a beta of 0.32. The firm's 50 day simple moving average is $57.37 and its 200 day simple moving average is $56.26.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.55%. The company had revenue of $9.95 million for the quarter.
Utah Medical Products Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th will be given a $0.305 dividend. The ex-dividend date of this dividend is Wednesday, September 17th. This represents a $1.22 annualized dividend and a dividend yield of 2.0%. Utah Medical Products's dividend payout ratio (DPR) is currently 32.62%.
Utah Medical Products Company Profile
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Recommended Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
